Originally published byThe Hill
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data…
🇺🇸
More news from United StatesUnited States
NORTH AMERICA
Related News
Trump talks fertilizer, fuel to farmers in Wisconsin, but also Reflecting Pool, fountains
9h ago
Trump says he hopes ‘less shackled’ Pulte shrinks intelligence agencies
14h ago
What will it take to get a vaccine for the Ebola strain driving the current outbreak?
1d ago
Pulte pick to lead DNI further jeopardizes path to renewing warrantless spy powers
1d ago
NASA ends MAVEN mission after Mars orbiter goes silent
2d ago